Paying for unfunded vaccines at your pharmacy
Part of Infections clinical trials.
This trial tests a way for you to get vaccines that are recommended but not free, like FluMist for kids, Shingrix for shingles, or RSV vaccines. You pay a copayment at a participating pharmacy instead of the full price.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be recommended for one of these vaccines: FluMist (ages 2-17), Shingrix (ages 50-64 in Nova Scotia, 50+ in Ontario, or 18+ if immunocompromised), or an RSV vaccine (ages 50+ for Arexvy, 60+ for Abrysvo).
- You must get the vaccine at a pharmacy that is part of this study in Nova Scotia or Ontario.
- You cannot already have private insurance that covers most or all of the vaccine cost.
- You cannot have already been fully vaccinated for that disease (e.g., already had the shingles or RSV vaccine).
- You must meet the general health guidelines for each vaccine (no contraindications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to make vaccination visits in community pharmacies better for both patients and pharmacy staff. It's for anyone getting a shot or working in a pharmacy that's part of the study.
This study looks at whether funding from the French National Health Insurance helps more people get recommended vaccines. It focuses on adults who need the pneumococcal vaccine and pregnant women who need the pertussis (whooping cough) vaccine.
This trial tests if offering points that can be redeemed for rewards, along with digital tools, can help more people get vaccinated. It uses community support to encourage participation and is open to adults who are able to follow the study requirements.
This trial tests if a set of actions can help reduce mistakes when giving vaccines in health units. It may help your unit improve safety and make sure shots are given correctly.
This study tests whether special training helps primary care doctors have better conversations with patients about flu and COVID-19 vaccines. You may be eligible if you're a patient who visits a participating clinic during the 2026–2027 vaccine season.
This trial tests if sending reminders and decision-support tools to patients and their doctors before appointments can increase vaccine acceptance. It focuses on families with children visiting a specific clinic in Atlanta.
Hear when a new Preventable Disease, Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.